“Bring Industry Partners on Board from Day One”: Dr Jitendra Singh Calls for New Industry–R&D Partnership Model
Union Minister Dr. Jitendra Singh called for a new industry-R&D partnership model at the 6th RISE Conclave in Kolkata, urging industry partners to be involved from the project-planning stage. Discussions during the event covered critical minerals, space technology, foundry sector R&D facilities, and indigenous anti-snake venom production. The Minister emphasized regulatory simplification and assured government support for actionable industry requirements.
Why It Matters
This press release is relevant for competitive exam aspirants (especially UPSC and state-PSC exams) covering topics related to science and technology policy, public-private partnerships in R&D, critical minerals, and industrial growth in India.
In Simple Words
Union Minister Dr. Jitendra Singh spoke at the 6th RISE Conclave at CSIR-IICB, Kolkata, advising that commercial partners should work with research labs right from day one of a project. Involving industry early helps shape technology according to market requirements, design, and commercial viability.
Discussions during the event covered critical minerals like rare earths, lithium, vanadium, and titanium, alongside space technology and foundry sector R&D. The Minister also addressed proposals regarding anti-snake venom production, stressing the need for clinical trials and proper scientific validation to ensure patient safety.
Key Points
- Dr. Jitendra Singh spoke at the 6th RISE Conclave at CSIR-IICB, Kolkata.
- He called for commercial partners to be associated at the project-planning stage.
- Discussions included critical minerals like rare-earth extraction, permanent magnets, recycling, and lithium beneficiation.
- Strategic minerals such as vanadium and titanium were discussed by participants.
- A common R&D facility for the foundry sector and steel-sector collaboration was suggested.
- Bengal Chemicals and Pharmaceuticals raised reviving indigenous production of anti-snake venom.
- A startup presented technologies for identifying snakebite species and developing new antivenom solutions, requiring clinical trials.
- The Minister noted that regulatory simplification has already been undertaken.
Exam Angle
A. CSIR-IICB, Kolkata
Source: Press Information Bureau